Rapid High-Sensitivity Detection of Antibodies to Trypanosoma cruzi With a Recombinant Tc24 Antigen-Based Magneto-Immunoassay: A Pilot Study
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf123 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Kavya L Singampalli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Rice University. Hauptthemen laut MEDLINE: Chagas Disease, Trypanosoma cruzi, Antigens, Protozoan, Antibodies, Protozoan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The diagnosis of chronic Chagas disease is challenging due to the wide genetic diversity of Trypanosoma cruzi, the causative agent of Chagas disease, and low levels of parasitemia, resulting in low sensitivity and accuracy with existing diagnostics. We report a magneto-immunoassay that employs dually labeled magnetic beads incorporating a recombinant Tc24 antigen, which is homologous across multiple discrete typing units of T cruzi. In this pilot study, 102 serum samples from 7 endemic countries were tested by this magneto-immunoassay, revealing its ability to distinguish Chagas-positive from Chagas-negative cases more accurately and faster than a standard Tc24-based immunoassay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Rice University.
- Medical Scientist Training Program, Baylor College of Medicine.
- Department of Pediatrics-Tropical Medicine, Baylor College of Medicine.
- Department of Mechanical Engineering, Rice University, Houston, Texas.
ORCID-Profile: Kavya L Singampalli, Rojelio Mejia, Peter B Lillehoj
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Singampalli, K. L., Zhan, B., Mejia, R., & Lillehoj, P. B. (2025). Rapid High-Sensitivity Detection of Antibodies to Trypanosoma cruzi With a Recombinant Tc24 Antigen-Based Magneto-Immunoassay: A Pilot Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf123
Vancouver
Singampalli KL, Zhan B, Mejia R, Lillehoj PB. Rapid High-Sensitivity Detection of Antibodies to Trypanosoma cruzi With a Recombinant Tc24 Antigen-Based Magneto-Immunoassay: A Pilot Study. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf123
BibTeX
@article{Singampalli2025,
author = {Singampalli, Kavya L and Zhan, Bin and Mejia, Rojelio and Lillehoj, Peter B},
title = {Rapid High-Sensitivity Detection of Antibodies to Trypanosoma cruzi With a Recombinant Tc24 Antigen-Based Magneto-Immunoassay: A Pilot Study},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf123}
}
EUVIMED